Your Cart
Your Cart is Empty
OUR EDITOR'S CHOICES
Healthy Aging & Longevity
OUR EDITOR'S CHOICES
Healthy Aging & Longevity
OUR EDITOR'S CHOICES
Healthy Aging & Longevity
Our Mission
To inspire and equip the world to reimagine a lifetime.
Our Approach
To disrupt people's beliefs about what it means to age by developing science-backed therapies that extend both healthspan and lifespan.
Our Commitment
To give you the tools and knowledge you need to take charge of your own aging journey.
Our Product
Metabolic Switch. Available Now.
Ketone Ester Fuel
Metabolic Switch
Your metabolism is your body’s core engine. Keep it strong, healthy and fueled with Metabolic Switch, C6 Ketone Di-ester.
Free shipping
Subscribe and receive 15% off
We see the emergence of a new healthcare approach where science fiction becomes science.
Dr. Greg Bailey
Chief Executive Officer and co-founder of Juvenescence
Our Divisions
We are organized to drive scientific innovation with speed and agility to market.
With a team of world class scientists, we’re targeting the fundamental molecular, cellular, and tissue pathways of aging. We identify pharmacotherapies of great potential and manage their development.
We are determined to become the trusted source for high quality, science-based consumer products. These non-Rx dietary products and functional foods support people as they manage their health and affect the onset of age-related conditions.
Artificial intelligence and machine learning will drive incredible efficiency and effectiveness in drug development. This is a key competitive advantage in pursuit of therapies that confront aging.
Our focus is on organ regeneration and the unlimited regenerative capacity of cells. We are making strategic investments and building a team at the forefront of the science of human aging.
In the News
Juvenescence
Longevity companies to watch in 2021
Juvenescence and its partners – the Buck Institute for Research on Aging, Insilico Medicine, and LyGenesis – have been identified as leaders who are driving important scientific advances in the longevity field.
January 4, 2021
Read MoreJuvenescence
M2Bio Sciences Interview: Dr. Greg Bailey Goes Deep on Juvenescence, Longevity Biotech, and His Personal Story
Dr. Greg Bailey, MD, CEO of Juvenescence, conducts an interview with M2Bio Sciences. In the interview, Greg shares his insights on Juvenescence, longevity biotech, entrepreneurship, and his personal story.
September 14, 2020
Read MoreJuvenescence
Allure: ‘Our Average Life Expectancy Could Increase to 115 Years Very Soon’
Dr. Greg Bailey, CEO of Juvenescence shares his insights on the future of aging with Allure. He discusses increasing lifespan in humans, a burst of investment in the longevity space and Juvenescence’s plans to bring that future to life.
August 18, 2020
Read More